Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia-Reference-Cited by-同舟云学术

Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia

Published:2022-11-18 Issue:1 Volume:37 Page:143-153
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ling Victoria Y.^ORCID,Straube Jasmin^ORCID,Godfrey William,Haldar Rohit,Janardhanan Yashaswini,Cooper Leanne,Bruedigam Claudia,Cooper Emily,Tavakoli Shirazi Paniz,Jacquelin Sebastien^ORCID,Tey Siok-Keen^ORCID,Baell Jonathan,Huang Fei^ORCID,Jin Jianwen,Zhao Yichao,Bullinger Lars,Bywater Megan J.,Lane Steven W.^ORCID

Funder

Department of Health | National Health and Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01755-2.pdf

Reference56 articles.

1. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.

2. Matthews J, Bishop J, Young G, Juneja S, Lowenthal R, Garson O, et al. Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia. Br J Haematol. 2001;113:727–36.

3. Ganzel C, Sun Z, Cripe LD, Fernandez HF, Douer D, Rowe JM, et al. Very poor long‐term survival in past and more recent studies for relapsed AML patients: the ECOG‐ACRIN experience. Am J Hematol. 2018;93:1074–81.